Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment

Liver cancer is the second leading cause of cancer‐related deaths, and hepatocellular carcinoma (HCC) is the most common type. Therefore, molecular targets are urgently required for the early detection of HCC and the development of novel therapeutic approaches. Glypican‐3 (GPC3), an oncofetal proteo...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Medicinal research reviews Ročník 38; číslo 2; s. 741 - 767
Hlavní autori:	Zhou, Fubo, Shang, Wenting, Yu, Xiaoling, Tian, Jie
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Wiley Subscription Services, Inc 01.03.2018
Predmet:	Biomarkers, Tumor - metabolism Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Disease Progression Glypicans - blood Glypicans - chemistry Glypicans - metabolism glypican‐3 hepatocellular carcinoma Humans Liver cancer Liver Neoplasms - blood Liver Neoplasms - diagnosis Liver Neoplasms - pathology Liver Neoplasms - therapy Medical imaging Molecular Targeted Therapy glypican-3 hepatocellular carcinoma
ISSN:	0198-6325, 1098-1128, 1098-1128
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!